Drivers and scorecards to improve hypertension control in primary care practice: Recommendations from the HEARTS in

Jeffrey W Brettler1,2, Gloria P Giraldo Arcila3, Teresa Aumala4

  • 1Southern California Permanente Medical Group, Los Angeles, CA, USA.

Insights

Improving hypertension control is crucial for reducing cardiovascular disease (CVD) in the Americas. The HEARTS in the Americas Initiative developed key drivers and scorecards to enhance hypertension management in primary care settings.

Area of Science:

  • Public Health
  • Cardiology
  • Health Services Research

Background:

  • Cardiovascular disease (CVD) remains a leading cause of death in the Americas, with hypertension as a primary modifiable risk factor.
  • Despite efforts, hypertension control rates are low, and CVD mortality is not declining as expected.
  • The World Health Organization's HEARTS technical package and the Pan American Health Organization's HEARTS in the Americas Initiative aim to improve CVD risk management, particularly hypertension control.

Purpose of the Study:

  • To identify key evidence-based drivers for effective hypertension control.
  • To develop a comprehensive scorecard for monitoring the implementation of these drivers in primary care.
  • To support quality improvement processes within the HEARTS in the Americas Initiative.

Main Methods:

  • An interdisciplinary group of practitioners identified essential hypertension control drivers.
  • High-performing health systems were studied to understand successful quality improvement strategies.
  • Drivers were translated into process measures and integrated into scorecards for the HEARTS in the Americas monitoring system.

Main Results:

  • Eight key drivers were selected, categorized into five domains: diagnosis, treatment, continuity of care, delivery system, and performance evaluation.
  • Two interconnected scorecards were developed to monitor these drivers.
  • The scorecards are integrated into the HEARTS in the Americas monitoring and evaluation system.

Conclusions:

  • Focusing on these selected hypertension drivers and utilizing the developed scorecards will guide quality improvement efforts.
  • This approach aims to achieve population-level hypertension control goals in participating countries.
  • The initiative supports health centers in implementing effective hypertension management strategies.
Abstract

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
36
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
41
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.1K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
48
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
963
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
71